US Stock MarketDetailed Quotes

TNYA Tenaya Therapeutics

Watchlist
  • 1.610
  • -0.050-3.01%
Close Dec 26 16:00 ET
  • 1.610
  • 0.0000.00%
Post 19:59 ET
127.55MMarket Cap-1.12P/E (TTM)

Tenaya Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.08%-19.84M
9.93%-23.62M
5.38%-28.66M
2.25%-102.07M
3.34%-21.92M
14.22%-23.64M
-3.11%-26.22M
-5.33%-30.29M
-71.72%-104.42M
-38.75%-22.68M
Net income from continuing operations
12.04%-25.63M
11.54%-29.43M
-1.55%-32.23M
-0.34%-124.08M
10.68%-29.94M
5.06%-29.14M
-17.16%-33.27M
-2.19%-31.74M
-70.05%-123.67M
-28.16%-33.52M
Depreciation and amortization
-3.67%2.1M
-3.28%2.12M
1.17%2.16M
34.33%8.69M
3.02%2.18M
4.50%2.18M
69.24%2.2M
120.50%2.13M
118.41%6.47M
167.64%2.12M
Other non cash items
31.96%1.12M
5.79%877K
11.91%902K
35.97%3.35M
-6.48%866K
18.77%848K
68.84%829K
142.77%806K
118.93%2.46M
142.41%926K
Change In working capital
-7.60%-1.32M
-383.89%-1.94M
17.97%-3.64M
-565.25%-5.65M
-113.45%-671K
53.95%-1.22M
135.15%683K
-259.19%-4.44M
-117.90%-849K
-33.17%4.99M
-Change in prepaid assets
-108.75%-112K
88.28%691K
22.13%447K
103.44%101K
-655.81%-1.91M
145.07%1.28M
131.37%367K
-50.00%366K
-7.47%-2.93M
15.05%344K
-Change in payables and accrued expense
72.29%-419K
-182.67%-1.84M
22.78%-3.08M
-117.08%-1.03M
-60.92%2.25M
-191.25%-1.51M
4,171.15%2.22M
-172.83%-3.99M
-49.49%6.01M
-24.69%5.76M
-Change in other current assets
266.18%249K
133.86%301K
-69.33%50K
26.26%-601K
139.86%57K
112.59%68K
-466.24%-889K
552.00%163K
73.83%-815K
-180.39%-143K
-Change in other current liabilities
2.36%-1.04M
-7.78%-1.1M
-8.07%-1.06M
-32.63%-4.12M
-9.55%-1.07M
-13.37%-1.06M
-52.10%-1.02M
-84.37%-979K
-137.43%-3.11M
-124.42%-974K
Cash from discontinued investing activities
Operating cash flow
16.08%-19.84M
9.93%-23.62M
5.38%-28.66M
2.25%-102.07M
3.34%-21.92M
14.22%-23.64M
-3.11%-26.22M
-5.33%-30.29M
-71.72%-104.42M
-38.75%-22.68M
Investing cash flow
Cash flow from continuing investing activities
-198.72%-30.1M
-13.83%21.62M
-155.69%-4.49M
-41.76%48.72M
-349.73%-14.92M
-1.76%30.49M
-16.96%25.09M
-50.95%8.06M
135.06%83.65M
109.55%5.97M
Net PPE purchase and sale
-2,200.00%-184K
64.90%-73K
10.33%-564K
93.99%-1.24M
50.44%-394K
99.80%-8K
97.10%-208K
92.68%-629K
17.88%-20.63M
93.67%-795K
Net investment purchase and sale
-198.12%-29.93M
-14.24%21.68M
-145.12%-3.93M
-52.07%49.98M
-314.57%-14.51M
-13.10%30.5M
-32.37%25.28M
-65.23%8.7M
148.85%104.27M
113.51%6.76M
Net other investing changes
400.00%12K
-55.56%4K
108.33%1K
-412.50%-25K
---18K
---4K
--9K
---12K
--8K
----
Cash from discontinued investing activities
Investing cash flow
-198.72%-30.1M
-13.83%21.62M
-155.69%-4.49M
-41.76%48.72M
-349.73%-14.92M
-1.76%30.49M
-16.96%25.09M
-50.95%8.06M
135.06%83.65M
109.55%5.97M
Financing cash flow
Cash flow from continuing financing activities
31K
-86.36%570K
9,435.53%46.77M
-94.79%4.05M
-99.52%371K
0
1,507.31%4.18M
-3,440.00%-501K
-62.79%77.77M
369,080.95%77.49M
Net common stock issuance
--0
--0
--46.76M
-95.00%3.87M
--0
--0
--3.87M
--0
-58.95%77.39M
121,017.19%77.39M
Proceeds from stock option exercised by employees
--31K
83.28%570K
--9K
79.47%682K
274.75%371K
--0
19.62%311K
--0
1.60%380K
219.35%99K
Net other financing activities
----
----
----
---501K
--0
--0
--0
---501K
----
----
Cash from discontinued financing activities
Financing cash flow
--31K
-86.36%570K
9,435.53%46.77M
-94.79%4.05M
-99.52%371K
--0
1,507.31%4.18M
-3,440.00%-501K
-62.79%77.77M
369,080.95%77.49M
Net cash flow
Beginning cash position
-22.94%58.55M
-17.76%59.99M
-51.54%46.36M
147.37%95.67M
137.40%82.84M
141.92%75.99M
176.62%72.94M
147.37%95.67M
-70.04%38.68M
-70.34%34.89M
Current changes in cash
-828.51%-49.9M
-147.04%-1.43M
159.93%13.62M
-186.51%-49.31M
-160.01%-36.47M
96.61%6.85M
-39.60%3.04M
-84.69%-22.73M
163.04%57M
176.98%60.78M
End cash Position
-89.56%8.65M
-22.94%58.55M
-17.76%59.99M
-51.54%46.36M
-51.54%46.36M
137.40%82.84M
141.92%75.99M
176.62%72.94M
147.37%95.67M
147.37%95.67M
Free cash flow
15.33%-20.02M
10.36%-23.69M
5.48%-29.22M
17.39%-103.31M
4.94%-22.32M
25.22%-23.65M
18.95%-26.43M
17.22%-30.92M
-45.53%-125.05M
18.77%-23.48M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.08%-19.84M9.93%-23.62M5.38%-28.66M2.25%-102.07M3.34%-21.92M14.22%-23.64M-3.11%-26.22M-5.33%-30.29M-71.72%-104.42M-38.75%-22.68M
Net income from continuing operations 12.04%-25.63M11.54%-29.43M-1.55%-32.23M-0.34%-124.08M10.68%-29.94M5.06%-29.14M-17.16%-33.27M-2.19%-31.74M-70.05%-123.67M-28.16%-33.52M
Depreciation and amortization -3.67%2.1M-3.28%2.12M1.17%2.16M34.33%8.69M3.02%2.18M4.50%2.18M69.24%2.2M120.50%2.13M118.41%6.47M167.64%2.12M
Other non cash items 31.96%1.12M5.79%877K11.91%902K35.97%3.35M-6.48%866K18.77%848K68.84%829K142.77%806K118.93%2.46M142.41%926K
Change In working capital -7.60%-1.32M-383.89%-1.94M17.97%-3.64M-565.25%-5.65M-113.45%-671K53.95%-1.22M135.15%683K-259.19%-4.44M-117.90%-849K-33.17%4.99M
-Change in prepaid assets -108.75%-112K88.28%691K22.13%447K103.44%101K-655.81%-1.91M145.07%1.28M131.37%367K-50.00%366K-7.47%-2.93M15.05%344K
-Change in payables and accrued expense 72.29%-419K-182.67%-1.84M22.78%-3.08M-117.08%-1.03M-60.92%2.25M-191.25%-1.51M4,171.15%2.22M-172.83%-3.99M-49.49%6.01M-24.69%5.76M
-Change in other current assets 266.18%249K133.86%301K-69.33%50K26.26%-601K139.86%57K112.59%68K-466.24%-889K552.00%163K73.83%-815K-180.39%-143K
-Change in other current liabilities 2.36%-1.04M-7.78%-1.1M-8.07%-1.06M-32.63%-4.12M-9.55%-1.07M-13.37%-1.06M-52.10%-1.02M-84.37%-979K-137.43%-3.11M-124.42%-974K
Cash from discontinued investing activities
Operating cash flow 16.08%-19.84M9.93%-23.62M5.38%-28.66M2.25%-102.07M3.34%-21.92M14.22%-23.64M-3.11%-26.22M-5.33%-30.29M-71.72%-104.42M-38.75%-22.68M
Investing cash flow
Cash flow from continuing investing activities -198.72%-30.1M-13.83%21.62M-155.69%-4.49M-41.76%48.72M-349.73%-14.92M-1.76%30.49M-16.96%25.09M-50.95%8.06M135.06%83.65M109.55%5.97M
Net PPE purchase and sale -2,200.00%-184K64.90%-73K10.33%-564K93.99%-1.24M50.44%-394K99.80%-8K97.10%-208K92.68%-629K17.88%-20.63M93.67%-795K
Net investment purchase and sale -198.12%-29.93M-14.24%21.68M-145.12%-3.93M-52.07%49.98M-314.57%-14.51M-13.10%30.5M-32.37%25.28M-65.23%8.7M148.85%104.27M113.51%6.76M
Net other investing changes 400.00%12K-55.56%4K108.33%1K-412.50%-25K---18K---4K--9K---12K--8K----
Cash from discontinued investing activities
Investing cash flow -198.72%-30.1M-13.83%21.62M-155.69%-4.49M-41.76%48.72M-349.73%-14.92M-1.76%30.49M-16.96%25.09M-50.95%8.06M135.06%83.65M109.55%5.97M
Financing cash flow
Cash flow from continuing financing activities 31K-86.36%570K9,435.53%46.77M-94.79%4.05M-99.52%371K01,507.31%4.18M-3,440.00%-501K-62.79%77.77M369,080.95%77.49M
Net common stock issuance --0--0--46.76M-95.00%3.87M--0--0--3.87M--0-58.95%77.39M121,017.19%77.39M
Proceeds from stock option exercised by employees --31K83.28%570K--9K79.47%682K274.75%371K--019.62%311K--01.60%380K219.35%99K
Net other financing activities ---------------501K--0--0--0---501K--------
Cash from discontinued financing activities
Financing cash flow --31K-86.36%570K9,435.53%46.77M-94.79%4.05M-99.52%371K--01,507.31%4.18M-3,440.00%-501K-62.79%77.77M369,080.95%77.49M
Net cash flow
Beginning cash position -22.94%58.55M-17.76%59.99M-51.54%46.36M147.37%95.67M137.40%82.84M141.92%75.99M176.62%72.94M147.37%95.67M-70.04%38.68M-70.34%34.89M
Current changes in cash -828.51%-49.9M-147.04%-1.43M159.93%13.62M-186.51%-49.31M-160.01%-36.47M96.61%6.85M-39.60%3.04M-84.69%-22.73M163.04%57M176.98%60.78M
End cash Position -89.56%8.65M-22.94%58.55M-17.76%59.99M-51.54%46.36M-51.54%46.36M137.40%82.84M141.92%75.99M176.62%72.94M147.37%95.67M147.37%95.67M
Free cash flow 15.33%-20.02M10.36%-23.69M5.48%-29.22M17.39%-103.31M4.94%-22.32M25.22%-23.65M18.95%-26.43M17.22%-30.92M-45.53%-125.05M18.77%-23.48M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.